Cargando…

Systematic review of model-based economic evaluations of heart valve implantations

OBJECTIVE: To review the evidence on the cost-effectiveness of heart valve implantations generated by decision analytic models and to assess their methodological quality. METHODS: A systematic review was performed including model-based cost-effectiveness analyses of heart valve implantations. Study...

Descripción completa

Detalles Bibliográficos
Autores principales: Huygens, Simone A., Takkenberg, Johanna. J. M., Rutten-van Mölken, Maureen P. M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813051/
https://www.ncbi.nlm.nih.gov/pubmed/28265822
http://dx.doi.org/10.1007/s10198-017-0880-z
_version_ 1783300111626928128
author Huygens, Simone A.
Takkenberg, Johanna. J. M.
Rutten-van Mölken, Maureen P. M. H.
author_facet Huygens, Simone A.
Takkenberg, Johanna. J. M.
Rutten-van Mölken, Maureen P. M. H.
author_sort Huygens, Simone A.
collection PubMed
description OBJECTIVE: To review the evidence on the cost-effectiveness of heart valve implantations generated by decision analytic models and to assess their methodological quality. METHODS: A systematic review was performed including model-based cost-effectiveness analyses of heart valve implantations. Study and model characteristics and cost-effectiveness results were extracted and the methodological quality was assessed using the Philips checklist. RESULTS: Fourteen decision-analytic models regarding the cost-effectiveness of heart valve implantations were identified. In most studies transcatheter aortic valve implantation (TAVI) was cost-effective compared to standard treatment (ST) in inoperable or high-risk operable patients (ICER range 18,421–120,779 €) and in all studies surgical aortic valve replacement (SAVR) was cost-effective compared to ST in operable patients (ICER range 14,108–40,944 €), but the results were not consistent on the cost-effectiveness of TAVI versus SAVR in high-risk operable patients (ICER range: dominant to dominated by SAVR). Mechanical mitral valve replacement (MVR) had the lowest costs per success compared to mitral valve repair and biological MVR. The methodological quality of the studies was moderate to good. CONCLUSION: This review showed that improvements can be made in the description and justification of methods and data sources, sensitivity analysis on extrapolation of results, subgroup analyses, consideration of methodological and structural uncertainty, and consistency (i.e. validity) of the models. There are several opportunities for future decision-analytic models of the cost-effectiveness of heart valve implantations: considering heart valve implantations in other valve positions besides the aortic valve, using a societal perspective, and developing patient-simulation models to investigate the impact of patient characteristics on outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10198-017-0880-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5813051
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58130512018-02-26 Systematic review of model-based economic evaluations of heart valve implantations Huygens, Simone A. Takkenberg, Johanna. J. M. Rutten-van Mölken, Maureen P. M. H. Eur J Health Econ Original Paper OBJECTIVE: To review the evidence on the cost-effectiveness of heart valve implantations generated by decision analytic models and to assess their methodological quality. METHODS: A systematic review was performed including model-based cost-effectiveness analyses of heart valve implantations. Study and model characteristics and cost-effectiveness results were extracted and the methodological quality was assessed using the Philips checklist. RESULTS: Fourteen decision-analytic models regarding the cost-effectiveness of heart valve implantations were identified. In most studies transcatheter aortic valve implantation (TAVI) was cost-effective compared to standard treatment (ST) in inoperable or high-risk operable patients (ICER range 18,421–120,779 €) and in all studies surgical aortic valve replacement (SAVR) was cost-effective compared to ST in operable patients (ICER range 14,108–40,944 €), but the results were not consistent on the cost-effectiveness of TAVI versus SAVR in high-risk operable patients (ICER range: dominant to dominated by SAVR). Mechanical mitral valve replacement (MVR) had the lowest costs per success compared to mitral valve repair and biological MVR. The methodological quality of the studies was moderate to good. CONCLUSION: This review showed that improvements can be made in the description and justification of methods and data sources, sensitivity analysis on extrapolation of results, subgroup analyses, consideration of methodological and structural uncertainty, and consistency (i.e. validity) of the models. There are several opportunities for future decision-analytic models of the cost-effectiveness of heart valve implantations: considering heart valve implantations in other valve positions besides the aortic valve, using a societal perspective, and developing patient-simulation models to investigate the impact of patient characteristics on outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10198-017-0880-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-03-06 2018 /pmc/articles/PMC5813051/ /pubmed/28265822 http://dx.doi.org/10.1007/s10198-017-0880-z Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Huygens, Simone A.
Takkenberg, Johanna. J. M.
Rutten-van Mölken, Maureen P. M. H.
Systematic review of model-based economic evaluations of heart valve implantations
title Systematic review of model-based economic evaluations of heart valve implantations
title_full Systematic review of model-based economic evaluations of heart valve implantations
title_fullStr Systematic review of model-based economic evaluations of heart valve implantations
title_full_unstemmed Systematic review of model-based economic evaluations of heart valve implantations
title_short Systematic review of model-based economic evaluations of heart valve implantations
title_sort systematic review of model-based economic evaluations of heart valve implantations
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813051/
https://www.ncbi.nlm.nih.gov/pubmed/28265822
http://dx.doi.org/10.1007/s10198-017-0880-z
work_keys_str_mv AT huygenssimonea systematicreviewofmodelbasedeconomicevaluationsofheartvalveimplantations
AT takkenbergjohannajm systematicreviewofmodelbasedeconomicevaluationsofheartvalveimplantations
AT ruttenvanmolkenmaureenpmh systematicreviewofmodelbasedeconomicevaluationsofheartvalveimplantations